A REVIEW OF NEMBUTAL ORAL LIQUID

pentobarbital will reduce the level or result of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic impact of elbasvir/grazoprevir could possibly be reduced if coadministered with solid CYP3A inducers and is particularly thus contraindicated.pentobarbital will minimize the extent or impac